Neuroscience Antibodies & Assays Market Growth Outlook Through 2024-2033

Overview and Scope
The neuroscience antibodies & assays are used to study the development, systems, structure and function, disorders, and degeneration of the nervous system. Neuroscience is the study of the nervous system, its working, and diseases related to the nervous system. Antibodies and assays is a medical test that is based on principles of interaction between antigenic epitopes and antibodies, and this test is useful in neuroscience and the study of neurological disorders.

Sizing and Forecast
The neuroscience antibodies & assays market size has grown rapidly in recent years. It will grow from <b>$4.1 billion in 2023 to $4.63 billion in 2024 at a compound annual growth rate (CAGR) of 13.0%. </b> The growth in the historic period can be attributed to research funding, drug discovery and development, neurodegenerative diseases, government initiatives, personalized medicine.

The neuroscience antibodies & assays market size is expected to see rapid growth in the next few years. It will grow to <b>$7.68 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. </b> The growth in the forecast period can be attributed to collaborations, telemedicine in neurology, education and training, biomarker-driven therapies, neuroimmunology focus . Major trends in the forecast period include microrna and non-coding rna assays, digital pathology, advanced imaging-compatible assays, single-cell analysis, 3d organoid models.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report

Segmentation & Regional Insights
The neuroscience antibodies & assays market covered in this report is segmented –

1) By Product: Consumables, Instruments
2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies
3) By Application: In Vitro Diagnostics, Research, Drug Discovery
4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies

<b>North America</b> was the largest region in the neuroscience antibodies & assays market in 2023. The regions covered in the neuroscience antibodies & assays market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7548&type=smp

Major Driver Impacting Market Growth
The increase in incidents of neurological illnesses across the globe are expected to propel the growth of the neuroscience antibodies & assays market going forward. Neurological illnesses are disorders and affecting the nervous system, and examples of neurological disorders include epilepsy, Alzheimer’s disease, dementia, and so on. The rise in the number of neurological illnesses requires more research and development activities for the treatment of these diseases. Antibodies and assays are used in research and development activities to study development, systems, structure and function, and disorders and degeneration of the nervous system. Thus, the neuroscience antibodies & assays market grows with the increase in incidents of neurological illnesses. For instance, According to the World Health Organization, a Switzerland-based health promotion agency 55 million people live with dementia globally, and there are nearly 10 million new cases every year as per 2021 data. According to Alzheimer’s Association a US based Non-profit association, 6.5 million people in the US have Alzheimer’s disease as per 2022 data. As a result, the increased incidence of neurological illnesses across the world is driving the neuroscience antibodies and assays market forward.

Key Industry Players
Major companies operating in the neuroscience antibodies & assays market include <b> Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB </b>

The neuroscience antibodies & assays market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model